Use your iPhone to Stay Informed

I don’t have an iPhone, but I am seriously considering getting one just because the apps are so darn cool. Here are few cancer related apps that I thought you might find interesting and if I missed any, please share:

TouchOut™ Cancer
TouchOut™ Cancer is a new way to stay informed with cancer information, bringing cancer news, knowledge and awareness to people each and every day. Organizations which will be contributing content include: Cancer Schmancer, The Leukemia & Lymphoma Society and I’m Too Young For This Cancer Foundation with more organization announcements forthcoming.

Celebrities such as Fran Drescher, Matisyahu, Olympic Gold Medalist Bryan Clay and more will provide upcoming celebrity updates. The free app will include prevention tips, new and updated clinical trials, stories of hope, information about cancer services and celebrity audio and video messages.

Heme Calc
For folks who want to do their own research, this free hematology app focuses on patients with benign or malignant hematologic disease. It includes calculators to determine Deep Vein Thrombosis Pre-test Probability, Bone Marrow Involvement in Hodgkin's Disease, Body Surface Area and Chemotherapy dosing, Febrile Neutropenia MASCC Risk Score, Epo/GCSF Response in Myelodysplastic Syndrome, Heparin Induced Thrombocytopenia (HIT) Score, Multiple Myeloma International Staging System and more.

Blausen Cancer Atlas
Provides a comprehensive set of cancer-related 3D animations, detailing 49 conditions and procedures. Whether cancer specialist, general practitioner, student or consumer, this is an ideal resource for communicating core concepts, right in the palm of your hand and right at point of care. Derived from the Blausen Medical award winning, world's largest medical animation library, the animations (each approximately 1-2 minutes in length) serve as an ideal starting point for patient understanding.

Blog Category: 

More Articles

More Articles

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

In a large trial of older, newly diagnosed patients with chronic lymphocytic leukemia (CLL),...

Today’s typical treatments have been unable to cure numerous types of lymphoma, but emerging immunotherapies could provide the key to...

Biotech firm Gilead Sciences Inc. has announced that the first patient has been dosed in a Phase III trial evaluating the safety and efficacy of...

Last week at the 54th American Society of Hematology Annual Meeting and Exposition in Atlanta, researchers out of MD Anderson Cancer Center in...

The results of a pair of long-term survival studies indicate the therapeutic value of BEXXAR (...

A new lab test that can improve survival rates among patients with chronic lymphocytic leukemia (...

Aggressive Non-Hodgkin’s Lymphomas (NHLs) are fast growing cancers (as opposed to indolent cancers). They involve...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Sitemap